Food and Drug Industry Exchange Meeting Concerning the Biologics Industry; Notice of Public Meetings

Resumo

The Food and Drug Administration's (FDA's), Atlanta District Office, Center for Biologics Evaluation and Research, and Office of Small Business, Scientific and Trade Affairs are cosponsoring public meetings with all persons involved in the blood bank, plasmapheresis, and associated laboratory industries. These meetings are intended to provide an exchange of information between FDA and the biologics industry on critical areas in which problems have been observed. Two meetings of comparable content will be held.